Literature DB >> 26630218

Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction.

Hye Hyun Yoo1, In Sook Kim, Dae-Hyeong Yoo, Dong-Hyun Kim.   

Abstract

BACKGROUND: Amlodipine is a representative calcium channel blocker that is frequently prescribed for the treatment of hypertension. In this study, the possibility of drug-drug interactions between amlodipine and coadministered antibiotics (ampicillin) was investigated in rats; thus, changes in the metabolic activities of gut microflora and the consequent pharmacokinetic pattern of amlodipine following ampicillin treatment were characterized. METHODS AND
RESULTS: In human and rat fecalase incubation samples, amlodipine was metabolized to yield a major pyridine metabolite. The remaining amlodipine decreased and the formation of pyridine metabolite increased with incubation time, indicating the involvement of gut microbiota in the metabolism of amlodipine. Pharmacokinetic analyses showed that systemic exposure of amlodipine was significantly elevated in antibiotic-treated rats compared with controls.
CONCLUSION: These results showed that antibiotic intake might increase the bioavailability of amlodipine by suppressing gut microbial metabolic activities, which could be followed by changes in therapeutic potency. Therefore, coadministration of amlodipine with antibiotics requires caution and clinical monitoring.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26630218     DOI: 10.1097/HJH.0000000000000773

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  28 in total

Review 1.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

Review 2.  Bioavailability Based on the Gut Microbiota: a New Perspective.

Authors:  Feng Zhang; Fang He; Li Li; Lichun Guo; Bin Zhang; Shuhuai Yu; Wei Zhao
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-29       Impact factor: 11.056

3.  Gut Microbiome and Response to Cardiovascular Drugs.

Authors:  Sony Tuteja; Jane F Ferguson
Journal:  Circ Genom Precis Med       Date:  2019-08-28

Review 4.  Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.

Authors:  YanFei Qi; Seungbum Kim; Elaine M Richards; Mohan K Raizada; Carl J Pepine
Journal:  Circ Res       Date:  2017-05-26       Impact factor: 17.367

Review 5.  Role of the microbiota in hypertension and antihypertensive drug metabolism.

Authors:  Eikan Mishima; Takaaki Abe
Journal:  Hypertens Res       Date:  2021-12-09       Impact factor: 3.872

Review 6.  Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?

Authors:  Khalid Mehmood; Afrasim Moin; Talib Hussain; Syed Mohd Danish Rizvi; D V Gowda; Shazi Shakil; M A Kamal
Journal:  Folia Microbiol (Praha)       Date:  2021-10-26       Impact factor: 2.099

7.  Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase.

Authors:  Kemin Tan; Christine Tesar; Rosemarie Wilton; Robert P Jedrzejczak; Andrzej Joachimiak
Journal:  Protein Sci       Date:  2018-07-10       Impact factor: 6.725

Review 8.  Immunity, microbiota and kidney disease.

Authors:  Felix Knauf; J Richard Brewer; Richard A Flavell
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

Review 9.  Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.

Authors:  Petra Mamic; Thanat Chaikijurajai; W H Wilson Tang
Journal:  J Mol Cell Cardiol       Date:  2020-12-09       Impact factor: 5.000

Review 10.  Gut Microbiome and Neuroinflammation in Hypertension.

Authors:  Elaine M Richards; Jing Li; Bruce R Stevens; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.